Eventide Asset Management’s Five Prime Therapeutics, Inc. FPRX Stock Holding History

Eventide Asset Management’s Portfolio FPRX Stock Details FPRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-105,000	Closed	-$1.8M	–	152
2018 Q1	$1.8M	Sell	105,000 -210,000	-67%	-$4.1M	0.08%	118
2017 Q4	$6.91M	Sell	315,000 -286,000	-48%	-$9.2M	0.36%	75
2017 Q3	$24.6M	Hold	601,000	–	–	1.39%	28
2017 Q2	$18.1M	Hold	601,000	–	–	1.13%	40
2017 Q1	$21.7M	Sell	601,000 -209,000	-26%	-$9.21M	1.44%	29
2016 Q4	$40.6M	Sell	810,000 -205,200	-20%	-$10.8M	2.64%	5
2016 Q3	$53.3M	Sell	1,015,200 -70,000	-6%	-$3.34M	3.25%	2
2016 Q2	$44.9M	Sell	1,085,200 -70,000	-6%	-$3.04M	2.75%	7
2016 Q1	$46.9M	Sell	1,155,200 -100,000	-8%	-$3.44M	2.62%	9
2015 Q4	$52.1M	Buy	1,255,200 +90,300	+8%	+$3.03M	2.6%	6
2015 Q3	$17.9M	Buy	1,164,900 +207,000	+22%	+$4.45M	1.04%	39
2015 Q2	$23.8M	Buy	957,900 +118,500	+14%	+$2.64M	1.29%	30
2015 Q1	$19.2M	Buy	839,400 +55,400	+7%	+$1.4M	1.44%	29
2014 Q4	$21.2M	Buy	784,000 +10,400	+1%	+$179K	2.31%	9
2014 Q3	$9.07M	Hold	773,600	–	–	1.27%	37
2014 Q2	$12M	Buy	773,600 +260,400	+51%	+$3.73M	1.64%	21
2014 Q1	$10.1M	Buy	+513,200	New	+$8.71M	1.57%	25

Other funds holding FPRX

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

GPP

Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Eventide Asset Management's FPRX Position: Q2 2018 in Review

Eventide Asset Management sold out of Five Prime Therapeutics, Inc. (FPRX) in Q2 2018, closing a stake of 105,000 shares — an estimated $1.8M sold.

Eventide Asset Management first reported a position in FPRX in Q1 2014 and held it in 17 quarters. The position peaked at $53.3M in Q3 2016. 123 funds tracked by Wall St. Rank hold FPRX as of Q2 2018.

Eventide Asset Management reported no remaining Five Prime Therapeutics, Inc. position as of Q2 2018 after selling out during the quarter.
Eventide Asset Management sold 105,000 Five Prime Therapeutics, Inc. shares in Q2 2018, an estimated $1.8M.
Eventide Asset Management first reported a position in Five Prime Therapeutics, Inc. in Q1 2014 and held it in 17 quarters.
Eventide Asset Management's Five Prime Therapeutics, Inc. position peaked at $53.3M in Q3 2016.
123 funds tracked by Wall St. Rank held Five Prime Therapeutics, Inc. as of Q2 2018.

Based on Eventide Asset Management's 13F filing for Q2 2018, filed 14 Aug 2018.